Microwash, a member of Bio Nebraska, is a comfortable and high-quality nasal specimen collection device providing a less invasive alternative to nasal swabs for labs, patients and healthcare providers.
Announcement from University Medical Devices
University Medical Devices (UMD) today announced the closure of its first round of seed funding. UMD – which brings to market cutting-edge healthcare technology from the University of Nebraska Medical Center and its commercialization wings UNeMed/UNeTech – raised $1.6 million to drive the company’s mission of revolutionizing healthcare diagnostics.
Funds are earmarked to advance UMD’s infrastructure, covering regulatory, medical, legal, manufacturing, packaging, sales and marketing. This funding round represents a major step toward UMD achieving profitability and sustainability, with a strong emphasis on bringing its first product – MicroWash – to market.
MicroWash plays a pivotal role in addressing the challenges posed by the “tripledemic” – flu, COVID and RSV – as well as other respiratory infections. Developed at the start of the COVID-19 pandemic, MicroWash is a comfortable and high-quality nasal specimen collection device providing a less invasive alternative to nasal swabs for labs, patients and healthcare providers. This collection system is especially crucial for higher-risk populations and a significant step toward mitigating the global impact of future pandemics.